Overview
Lymphoproliferative syndrome is a term that has been used to describe a group of conditions where the immune system produces too many white blood cells called lymphocytes. This entry in Orphanet (code 238510) is now marked as OBSOLETE, meaning it has been retired and replaced by more specific disease classifications. The conditions previously grouped under this name are now categorized under more precise diagnoses such as autoimmune lymphoproliferative syndrome (ALPS), X-linked lymphoproliferative disease (XLP), or other specific lymphoproliferative disorders. In these conditions, the body's lymphocytes grow and multiply in an uncontrolled way, which can lead to enlarged lymph nodes, an enlarged spleen, an enlarged liver, and problems with the immune system. Some forms are inherited and caused by genetic mutations that affect how lymphocytes normally die off when they are no longer needed. Without proper cell death (called apoptosis), these extra immune cells build up and can cause autoimmune problems, where the body attacks its own healthy tissues. Because this is an obsolete classification, patients who were previously diagnosed under this umbrella term should work with their doctors to determine which specific lymphoproliferative condition they have. Treatment varies widely depending on the exact diagnosis but may include immunosuppressive medications, targeted therapies, monitoring for lymphoma, and in some cases bone marrow transplantation.
Key symptoms:
Swollen lymph nodes throughout the bodyEnlarged spleenEnlarged liverFrequent or unusual infectionsLow red blood cell count (anemia)Low platelet count causing easy bruising or bleedingFatigue and tirednessFever without clear causeAutoimmune problems where the body attacks its own cellsSkin rashesUnexplained weight lossNight sweats
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
2 eventsNational Institute of Allergy and Infectious Diseases (NIAID) — PHASE2
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Lymphoproliferative syndrome.
2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Lymphoproliferative syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Lymphoproliferative syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Lymphoproliferative syndrome.
Start the conversation →Latest news about OBSOLETE: Lymphoproliferative syndrome
No recent news articles for OBSOLETE: Lymphoproliferative syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific type of lymphoproliferative syndrome do I or my child have?,What genetic testing should be done to confirm the diagnosis?,What is the risk of developing lymphoma, and how will you monitor for it?,What medications are recommended, and what are their side effects?,Is bone marrow transplant an option for my specific condition?,Are other family members at risk and should they be tested?,What symptoms should prompt me to go to the emergency room?
Common questions about OBSOLETE: Lymphoproliferative syndrome
What is OBSOLETE: Lymphoproliferative syndrome?
Lymphoproliferative syndrome is a term that has been used to describe a group of conditions where the immune system produces too many white blood cells called lymphocytes. This entry in Orphanet (code 238510) is now marked as OBSOLETE, meaning it has been retired and replaced by more specific disease classifications. The conditions previously grouped under this name are now categorized under more precise diagnoses such as autoimmune lymphoproliferative syndrome (ALPS), X-linked lymphoproliferative disease (XLP), or other specific lymphoproliferative disorders. In these conditions, the body's
Are there clinical trials for OBSOLETE: Lymphoproliferative syndrome?
Yes — 2 recruiting clinical trials are currently listed for OBSOLETE: Lymphoproliferative syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.